Financial Performance - The company's operating revenue for Q1 2019 was ¥200,816,847.02, representing a 20.15% increase compared to ¥164,337,923.65 in the same period last year[8] - Net profit attributable to shareholders was ¥5,634,016.68, up 27.69% from ¥3,450,003.69 year-on-year[8] - The net profit after deducting non-recurring gains and losses was ¥5,615,209.76, reflecting a 29.62% increase from ¥3,369,654.81 in the previous year[8] - Basic and diluted earnings per share were both ¥0.0465, a 19.54% increase from ¥0.0304 in the previous year[8] - Net profit for the current period was ¥6,684,874.50, representing a 33.05% increase from ¥5,026,679.27 in the previous period[56] - The company reported a total comprehensive income of ¥6,684,874.50 for the current period, up from ¥5,026,679.27 in the previous period[66] Cash Flow - The net cash flow from operating activities improved significantly to -¥43,604,054.30, a 65.28% improvement from -¥104,583,392.00 in the same period last year[8] - Operating cash inflow for the current period was CNY 645,817,086.42, an increase of 60.7% compared to CNY 401,474,909.22 in the previous period[71] - The net cash flow from operating activities was -CNY 43,604,054.30, an improvement from -CNY 125,578,841.90 in the previous period[71] - Cash outflow for operating activities totaled CNY 689,421,140.72, up from CNY 527,053,751.12, indicating a rise of 30.8%[71] - The ending cash and cash equivalents balance was CNY 137,254,847.59, compared to CNY 106,623,640.01 at the end of the previous period[74] - The company reported a cash and cash equivalents net decrease of -CNY 70,026,343.38, compared to -CNY 57,629,477.01 in the previous period[74] Assets and Liabilities - Total assets at the end of the reporting period were ¥969,197,961.49, a 3.71% increase from ¥934,528,473.56 at the end of the previous year[8] - Total liabilities increased to ¥458,079,213.56, up from ¥430,094,600.13, representing a growth of approximately 6.4%[39] - Current liabilities totaled ¥458,078,925.83, compared to ¥430,094,312.40, indicating an increase of about 6.5%[39] - The total equity attributable to shareholders rose to ¥479,914,128.87 from ¥474,280,112.19, reflecting a growth of around 1.4%[41] - The total current assets increased to ¥528,340,484.41 from ¥507,798,409.29, reflecting a growth of approximately 4.9%[45] Expenses - R&D expenses rose by 103.72% to ¥7,511,914.90, primarily due to increased salaries for R&D personnel[22] - Tax expenses increased by 46.53% to ¥1,873,360.84, mainly due to an increase in total profit[22] - Management expenses increased by 38.19% to ¥12,646,437.62, mainly due to higher salaries and consulting fees[22] - Financial expenses increased by 33.81% to ¥1,002,588.22, primarily due to increased bank loan interest[22] - Cash paid for taxes increased by 64.31% to ¥14,077,269.16, primarily due to an increase in value-added tax[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,311, with the largest shareholder holding 30.77% of the shares[13] - The company did not engage in any repurchase transactions among its top shareholders during the reporting period[16] Future Projections - The company expects net profit for the first half of 2019 to increase by over 50% year-on-year, with a projected range of ¥1,220.54 million to ¥1,550.41 million[26]
东方中科(002819) - 2019 Q1 - 季度财报